BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16421147)

  • 21. [Anti-neuronal nuclear antibodies, type 1 and type 2].
    Hirose G
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():522-5. PubMed ID: 20942119
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures.
    Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Jaskowski TD; Carlson NG
    J Neuroinflammation; 2014 Sep; 11():160. PubMed ID: 25228406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
    Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
    Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Ri antibody positive opsoclonus-myoclonus in a male patient with breast carcinoma.
    Wirtz PW; Sillevis Smitt PA; Hoff JI; de Leeuw B; Lammers GJ; van Duinen SG; Verschuuren JJ
    J Neurol; 2002 Dec; 249(12):1710-2. PubMed ID: 12529794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demonstration of anti-HuD specific oligoclonal bands in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes. Qualitative evidence of anti-HuD specific IgG-synthesis in the central nervous system.
    Rauer S; Kaiser R
    J Neuroimmunol; 2000 Nov; 111(1-2):241-4. PubMed ID: 11063845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ophthalmoplegia associated with the anti-Ri antibody.
    Ohmer R; Golnik KC; Richards AI; Kosmorsky GS
    J Neuroophthalmol; 1999 Dec; 19(4):246-8. PubMed ID: 10608678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases.
    Aguirre-Cruz L; Charuel JL; Carpentier AF; Benyahia B; Delattre JY; Musset L
    J Neurooncol; 2005 Jan; 71(1):39-41. PubMed ID: 15719273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraneoplastic "stiff person syndrome" with metastatic adenocarcinoma and anti-Ri antibodies.
    McCabe DJ; Turner NC; Chao D; Leff A; Gregson NA; Womersley HJ; Mak I; Perkin GD; Schapira AH
    Neurology; 2004 Apr; 62(8):1402-4. PubMed ID: 15111682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Paraneoplastic neurological autoimmune diseases].
    Voltz R
    Dtsch Med Wochenschr; 2004 Aug; 129(33):1743-6. PubMed ID: 15295685
    [No Abstract]   [Full Text] [Related]  

  • 30. Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.
    Rojas-Marcos I; Picard G; Chinchón D; Gelpi E; Psimaras D; Giometto B; Delattre JY; Honnorat J; Graus F
    Neuro Oncol; 2012 Apr; 14(4):506-10. PubMed ID: 22351748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological mechanisms in paraneoplastic peripheral neuropathy.
    Antoine JC
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):61-72. PubMed ID: 11064827
    [No Abstract]   [Full Text] [Related]  

  • 32. Atypical paraneoplastic brainstem encephalitis associated with anti-ri-antibodies due to thymic carcinoma with possible clinical response to immunoglobulins.
    Kastrup O; Meyring S; Diener HC
    Eur Neurol; 2001; 45(4):285-7. PubMed ID: 11385271
    [No Abstract]   [Full Text] [Related]  

  • 33. Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome.
    Vogrig A; Joubert B; Maureille A; Thomas L; Bernard E; Streichenberger N; Cotton F; Ducray F; Honnorat J
    J Neurol; 2019 Feb; 266(2):398-410. PubMed ID: 30498914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autoantibodies in Paraneoplastic Neurological Syndrome].
    Kawachi I
    Brain Nerve; 2018 Apr; 70(4):329-339. PubMed ID: 29632281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic tests: Anti-Purkinje cell antibody (Anti-Yo/type 1 antibody)].
    Tanaka K
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():479-82. PubMed ID: 16111307
    [No Abstract]   [Full Text] [Related]  

  • 36. Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique.
    Knudsen A; Monstad SE; Dørum A; Lønning PE; Salvesen HB; Drivsholm L; Aarseth JH; Vedeler CA
    Cancer Immunol Immunother; 2006 Oct; 55(10):1280-4. PubMed ID: 16429314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study.
    Brieva-Ruíz L; Diaz-Hurtado M; Matias-Guiu X; Márquez-Medina D; Tarragona J; Graus F
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1044-6. PubMed ID: 18701208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity.
    Darnell RB
    Arch Neurol; 2004 Jan; 61(1):30-2. PubMed ID: 14732616
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-Ri-associated paraneoplastic cerebellar degeneration. Report of a case and revision of the literature.
    Mancuso M; Orsucci D; Bacci A; Caldarazzo Ienco E; Siciliano G
    Arch Ital Biol; 2011 Sep; 149(3):318-22. PubMed ID: 22028093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hu, Yo, Ri, Ma, Ta: monosyllabic answers to complex questions.
    Verschuuren J
    J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):742. PubMed ID: 18559456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.